Clinical Trial Update: Ivabradine for Long-Term Effects of COVID-19 With POTS Cohort [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating ivabradine for long-term effects of COVID-19 in a Postural Orthostatic Tachycardia Syndrome cohort is listed with unknown stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Haul Covid
• Postural Orthostatic Tachycardia Syndrome

Drugs mentioned

• IVABRADINE

Snippet

Sponsor: Uniformed Services University of the Health Sciences | Conditions: Long Haul COVID, Postural Orthostatic Tachycardia Syndrome | Phase 4 | Status: UNKNOWN